Inactive Instrument

News Claritas Pharmaceuticals Toronto S.E.

Equities

KLY

CA1806341071

Summary

Unlock all the news: Be the first to know and act before the market!

Claritas Pharmaceuticals : Updates Proposed Financing with Obsidian, Receives Australian Tax Credit, Starts Phase 1 Study of R-107	21-08-18	MT
Claritas Pharmaceuticals : IIROC Trading Resumption - CLAS	21-08-18	AQ
Claritas Announces Proposed Financing with Obsidian Global GP, LLC, Receipt of Australian Tax Credit, and Start of Phase 1 Clinical Study of R-107	21-08-18	GL
Claritas Pharmaceuticals : IIROC Trading Halt - CLAS	21-08-18	AQ
Claritas Announces Grant of Stock Options to Directors and Officers	21-07-27	GL
Claritas Pharmaceuticals : Cites Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with Severe COVID-19 Pneumonia as Validation of the Company’s Nitric Oxide-Releasing Compound, R-107	21-07-26	AQ
Claritas Pharmaceuticals, Inc. Announces Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with Severe Covid-19 Pneumonia as Validation of the Company’s Nitric Oxide-Releasing Compound, R-107	21-07-26	CI
Reverse Split: 1 of 20	21-07-22	FA
Claritas Pharmaceuticals : Reports Additional Data in Animal Model of Pulmonary Arterial Hypertension Treatment, R-107	21-07-21	MT
Claritas Pharmaceuticals, Inc. Announces Additional Data in Validated Animal Model of PAH Demonstrating Ability of R-107 to Prevent, Treat, and Reverse Established Disease	21-07-21	CI
Claritas Announces Additional Data in Validated Animal Model of PAH Demonstrating Ability of R-107 to Prevent, Treat, and Reverse Established Disease	21-07-21	GL
Claritas Pharmaceuticals : 1-For-20 Share Consolidation Effective July 23	21-07-20	MT
Claritas Announces Effective Date for Share Consolidation	21-07-20	GL
Claritas Pharmaceuticals, Inc.(TSXV:CLAS) dropped from S&P/TSX Venture Composite Index	21-07-19	CI
Claritas Pharmaceuticals : Announces Commitments from Company's Largest Shareholders to Vote for Approval of Share Consolidation	21-06-11	AQ
Claritas Announces Commitments from Company’s Largest Shareholders to Vote for Approval of Share Consolidation	21-06-10	GL
Claritas Announces Transfer of GVHD Program and Cancellation of Related Debt as Company Focuses on Nitric Oxide Therapeutics	21-06-01	GL
Claritas Pharmaceuticals : Announces Settlement of Debt Transaction	21-05-31	AQ
Claritas Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-28	CI
Claritas Pharmaceuticals Issues Letter to Shareholders	21-05-11	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Claritas Pharmaceuticals Toronto S.E.

Equities

KLY

CA1806341071

Summary

Filters